Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2020

Development of a Torque-Based Device for the Quantification of
Arm Rigidity in Patients with Parkinson’s Disease
Georgina O. Miller
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Biological Engineering Commons, Biomechanics and Biotransport Commons, Biomedical
Devices and Instrumentation Commons, Neurology Commons, Other Analytical, Diagnostic and
Therapeutic Techniques and Equipment Commons, and the Other Biomedical Engineering and
Bioengineering Commons
© Georgina O. Miller

Downloaded from
https://scholarscompass.vcu.edu/etd/6304

This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has
been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass.
For more information, please contact libcompass@vcu.edu.

© Georgina O. Miller 2020
All Rights Reserved

Development of a Torque-Based Device for the Quantification of Arm Rigidity in Patients with
Parkinson’s Disease

A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at
Virginia Commonwealth University
By
Georgina O. Miller
Bachelor of Science, General Engineering, Sweet Briar College, 2011

Director: Paul A. Wetzel, Ph.D.
Associate Professor, Department of Biomedical Engineering

Virginia Commonwealth University
Richmond, VA
May 2020

Acknowledgements
I would like to express my deep gratitude to Dr. Paul Wetzel for his continuous support and
guidance throughout my research. His vast knowledge especially that of systems engineering, electrical
engineering, neurodegenerative brain disorders, and human factors has taught me more than I thought
possible. He has also been a mentor to me throughout my graduate career at VCU and I know without his
guidance I would not have made it to this point.
In addition to my advisor, I would like to thank my thesis committee: Dr. Mark Baron and Dr.
Ding-Yu Fei for their support.
To my fellow classmates and lab mates, especially George Weistroffer, thank you for all the
thought-provoking conversations, collaborations, assistance, and words of encouragement.
I would also like to express my sincere thanks to ADVANCED Motion Controls®, for supplying
the controller through their university outreach program that allowed us to continue the device build and
complete this research project.
Lastly, I would like to thank my family and friends, especially my parents and Alex. To my
parents, thank you for all the love, support, and advice that you have shown me not only during my
graduate studies but throughout my entire life. Your continued support above and beyond that of even the
most wonderful parents is truly the only reason I am where I am today. Without you, I would not have
learned the values of hard work and determination and without your support during my failures I would
not know the true value of success. To Alex, thank you for sticking by my side through the many long
years of my academic life. I know the past six years of distance has not been easy but your support
throughout this process has meant the world to me and I appreciate it more than words can express.

ii

Table of Contents
List of Figures ............................................................................................................................................... v
List of Tables .............................................................................................................................................. vii
Abstract ...................................................................................................................................................... viii
Introduction ............................................................................................................................................ 1
Symptoms of Parkinson’s Disease ................................................................................................... 1
Symptom Presentation ..................................................................................................................... 2
Parkinsonian Rigidity....................................................................................................................... 3
Clinical Standard for Rigidity Assessment ...................................................................................... 3
Diagnosing PD ................................................................................................................................. 4
Clinical Standard for Diagnosis ....................................................................................................... 4
MDS-PD Diagnostic Criteria ........................................................................................................... 5
Subjective Rating Scales .................................................................................................................. 5
Movement Disorder Society’s – Unified Parkinson’s Disease Rating Scale ...................... 6
Hoehn and Yahr Scale ........................................................................................................ 6
Parksinson’s Disease Questionnaire - 39 ........................................................................... 7
Previous Attempts .................................................................................................................................. 8
Motivation ........................................................................................................................................ 8
Rater-driven Sensor Devices............................................................................................................ 9
Power-driven Sensor Devices ........................................................................................................ 10
Methods ................................................................................................................................................ 12
Device Setup .................................................................................................................................. 12
Features of the Motor Assembly .................................................................................................... 14
Controller/Power Assembly ........................................................................................................... 15
Hardware Safety Features .............................................................................................................. 16
Position Limit .................................................................................................................... 17
Torque and Velocity Limits ............................................................................................... 18
Position, Torque, and Velocity Create the Inhibit Signal ................................................. 19
Additional Components of the Safety Circuit.................................................................... 20
Connections Between Assemblies ................................................................................................. 21
Participants..................................................................................................................................... 21
Evaluative Protocol ........................................................................................................................ 22
Data Analyses ................................................................................................................................ 23
Results .................................................................................................................................................. 23

iii

Comparison of Velocity to Stimulus Position................................................................................ 23
Quantification of Perceived Rigidity in Co-contracted Versus Relaxed Trials ............................. 24
Stimulus Frequency Content .......................................................................................................... 32
Device Rumble .............................................................................................................................. 32
Discussion ............................................................................................................................................ 36
Sine, Discussion Ramp and Random Waveform Characterization ................................................ 36
Calculated Variance ....................................................................................................................... 37
Frequency Response (DFT) ........................................................................................................... 37
Limitations and Suggested Improvements ..................................................................................... 37
Future Directions and Conclusions ................................................................................................ 39
References ................................................................................................................................................... 40
Appendix 1: Parts List ................................................................................................................................ 43
Appendix 2: Resistor and Capacitor List .................................................................................................... 44

iv

List of Figures
Figure 1: Decreased dopaminergic neurons cause a lack of pigmentation in the brain ................................ 1
Figure 2: Types of Rigidity (Wang et al., 2014) ........................................................................................... 3
Figure 3: Device Setup (not pictured: computer, D/A, and A/D converters).............................................. 12
Figure 4: Isolation Transformer Block Diagram......................................................................................... 13
Figure 5: Device Block Diagram ................................................................................................................ 13
Figure 6: Motor Assembly (not pictured: mounted optical switches, DB-15 inter-assembly connector)... 14
Figure 7: 3D model of the photologic optical switch mount ...................................................................... 14
Figure 8: 3D model of a shaft collar ........................................................................................................... 14
Figure 9: Controller/Power Assembly front view ....................................................................................... 15
Figure 10: Controller/Power Assembly top view........................................................................................ 15
Figure 11: Controller/Power Assembly rear view ...................................................................................... 15
Figure 12: Safety circuit board (front view) ............................................................................................... 16
Figure 13: Safety circuit board (back view and wire wrap connections) .................................................... 16
Figure 14: Logic Circuit Schematic ............................................................................................................ 17
Figure 15: Visual representation of the position limit viewed from above transected shaft. ...................... 17
Figure 16: High Pass Filter Schematic ........................................................................................................ 18
Figure 17: NOR Logic ................................................................................................................................ 19
Figure 18: Set-Reset Latch Logic. Output = Q ........................................................................................... 19
Figure 19: Negative Voltage Converter Schematic .................................................................................... 20
Figure 20: Adjustable Regulator Schematic ............................................................................................... 20
Figure 21: 5V regulator Schematic ............................................................................................................. 20
Figure 22: Potentiometer Offset-Summing Amplifier Schematic .............................................................. 21
Figure 23: Arm shown during relaxation .................................................................................................... 22
Figure 24: Arm shown during co-contraction or clenched-fist phase ......................................................... 22
Figure 25: Values for position and velocity with device under the “no-load” condition............................ 24

v

Figure 26: Torque values for the Random stimulus with no load. .............................................................. 24
Figure 27: Torque values for the Random stimulus during relaxation for GM. ......................................... 25
Figure 28: Torque values for the Random stimulus during co-contraction for GM. .................................. 25
Figure 29: Torque values for the Random stimulus during relaxation for PW. .......................................... 26
Figure 30: Torque values for the Random stimulus during co-contraction for PW. ................................... 26
Figure 31: Torque values for the Sine stimulus with no load. .................................................................... 27
Figure 32: Torque values for the Sine stimulus during relaxation for GM. ................................................ 27
Figure 33: Torque values for the Sine stimulus during co-contraction for GM. ......................................... 27
Figure 34: Torque values for the Sine stimulus during relaxation for PW. ................................................ 28
Figure 35: Torque values for the Sine stimulus during co-contraction for PW. ......................................... 28
Figure 36: Torque values for the Ramp stimulus with no load. .................................................................. 29
Figure 37: Torque values for the Ramp stimulus during relaxation for GM. ............................................. 29
Figure 38: Torque values for the Ramp stimulus during co-contraction for GM. ...................................... 29
Figure 39: Torque values for the Ramp stimulus during relaxation for PW. .............................................. 30
Figure 40: Torque values for the Ramp stimulus during co-contraction for PW. ....................................... 30
Figure 41: Frequency content of position in the random stimulus.............................................................. 32
Figure 42: Yaw of the device during relaxation for GM and PW vs. during no-load condition................. 33
Figure 43: Yaw of the device during co-contraction for GM and PW vs. during no-load condition.......... 33
Figure 44: Pitch of the device during relaxation for GM and PW vs. during no-load condition. ............... 34
Figure 45: Pitch of the device during co-contraction for GM and PW vs. during no-load condition. ........ 34
Figure 46: Roll of the device during relaxation for GM and PW vs. during no-load condition. ................ 35
Figure 47: Roll of the device during co-contraction for GM and PW vs. during no-load condition. ......... 35

vi

List of Tables
Table 1: MDS Clinical Diagnostic Criteria for Parkinson’s Disease ............................................................ 5
Table 2: Mean and variance values for torque from the random stimulus .................................................. 31
Table 3: Mean and variance values for torque from the ramp stimulus ...................................................... 31
Table 4: Mean and variance values for torque from the sine stimulus ....................................................... 31

vii

Abstract

Development of a Torque-Based Device for the Quantification of Arm Rigidity in Patients with
Parkinson’s Disease

Georgina O. Miller, M.S.

A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in
Biomedical Engineering at Virginia Commonwealth University

Major Director: Paul A. Wetzel, Ph.D., Associate Professor, Department of Biomedical Engineering

Virginia Commonwealth University
Richmond, VA
May 2020

Parkinsonian rigidity is caused by the inability of the muscles to relax and extend properly, due to
reduced dopamine levels and often begins on one side of the body before spreading contralaterally. The
current standard for determining joint rigidity in a clinical setting is a test completed by the clinician
based on the feel of the relaxed wrist and elbow joints as they are passively flexed and extended and a
series of ordinal rating scales, the Movement Disorder Society’s – Unified Parkinson’s Disease Rating
Scale (MDS-UPDRS), Hoehn and Yahr Scale (H&Y), and Parkinson’s Disease Questionnaire-39 (PDQ39). These methods are used to determine the severity of the patient’s disease and the impact it has on
their quality of life, but they lack objectivity and do not differentiate between individual symptoms. We
present a torque-based device to objectively quantify rigidity in a PD patient’s arm. The device employs a
servo motor-shaft assembly, connected to a rigid forearm sling, and controlled by a computer to passively
flex and extend the elbow joint laterally. Two individuals were used for preliminary results in lieu of the
patient restrictions due to COVID-19. A sine, ramp, and random (sine-like) stimuli were used on each
person during a relaxed phase, and a co-contracted or clenched-fist phase. A torque transducer and
potentiometer measured the torque and position with respect to time while angle of rotation, acceleration,
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and velocity of the shaft were monitored simultaneously to ensure safety. Results showed that the
magnitude of rigidity was greater during co-contraction than during relaxation indicating that rigidity can
be objectively measured using this device. Quantifying joint rigidity will allow for a better understanding
of the mechanisms of rigidity in Parkinson’s and other movement disorders.

ix

Introduction
Parkinson’s Disease (PD) is a neurodegenerative condition, with no cure, brought on by the
selective death of dopaminergic neurons in the substantia nigra region of the midbrain. PD occurs most
often in those over the age of 50, with the average age of onset at 60, and affects more than 10 million
individuals worldwide and more than one million individuals in the United States making it the second
most prevalent neurodegenerative disease in the U.S. behind Alzheimer’s Disease (Elkouzi, n.d.). In
addition to a few environmental factors, some genetic factors have been identified, though they are
extremely rare occurring in only 5-10% of patients (Tysnes & Storstein, 2017). The presence of Lewy
bodies made up of clumping alpha-synuclein proteins in the substantia nigra is also considered a possible
link to PD but the significance of these Lewy bodies and their increased presence in the substantia nigra is
not well understood (Tysnes & Storstein, 2017).

Symptoms of Parkinson’s Disease
Despite a lack of understanding concerning the cause of
PD itself, significant research has been conducted to determine the
cause of PDs hallmark symptoms. The dopaminergic neurons in
the substantia nigra are responsible for secreting dopamine, a
neurotransmitter vital to many pathways in the brain including
those involved in motor control, motivation, and reward (Perry,
2015). During motor control, nigral neurons use dopamine to

Figure 1: Decreased dopaminergic neurons
cause a lack of pigmentation in the brain
(https://medlineplus.gov/ency/imagepages/19515.htm)

interact with movement regulating neurons in the basal ganglia
as part of the biochemical sequence that allows for fine motor control (Triarhou, 2000-2013). Without this
communication between the substantia nigra and basal ganglia, movements would be delayed and
uncoordinated (Perry, 2015). As a result of the substantial decrease in dopamine levels, caused by
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dopaminergic neuronal cell death, a decrease in this essential biochemical communication occurs leading
to the presence of the corresponding symptoms.
PD symptoms are divided into two main categories, motor symptoms including, bradykinesia,
tremor, rigidity, dystonia, dyskinesia, freezing, masked face, shuffling gait, postural instability, and soft
speech; and non-motor symptoms including, constipation, excessive sweating, fatigue, hallucinations and
delusions, mood disorders such as depression and anxiety, sleep disorders, and vision problems all of
which can worsen as time progresses (Spears, (n.d.) a ; Spears, (n.d.) b). As the disease state progresses
and the presenting symptoms worsen, the increased disability and complications that arise often
deteriorate the patient’s quality of life (QoL) (Bhidayasiri & Martinez-Martin, 2017).

Symptom Presentation
Parkinson’s Disease is known as an individual condition, meaning symptom presentation varies
from one patient to the next and presented symptoms appear and evolve at different rates for each patient
as well, although most individuals don’t begin noticing symptoms until years after they develop PD
(Barmore, n.d.). There is evidence that the initiation of dopaminergic neurodegeneration occurs decades
before the manifestation of any motor symptoms, presenting non-motor prodromal symptoms that alone
would not necessarily point to PD, such as constipation and REM-Sleep Behavior Disorder (RBD),
effectively evading diagnosis based on current diagnostic standards (Mantri & Morley, 2018). This latent
and early stage of PD has been named Prodromal-PD and is defined by Mantri and Morley (2018) as “the
stage at which individuals do not fulfill diagnostic criteria for PD…but do exhibit signs and symptoms
that indicate a higher than average risk of developing motor symptoms and a diagnosis of PD in the
future”.
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Parkinsonian Rigidity
Though each patient will experience many non-motor and
motor symptoms, the most associated and diagnostically relevant
symptoms caused by the death of these neuronal cells, are movement
related, including tremor, rigidity, and bradykinesia (Guttman &
Furukawa, 2003). Joint rigidity, one of the key indicators, results from
the inability of the muscles to relax and extend properly due to an

Figure 2: Types of Rigidity (Wang et
al., 2014)

increase in passive stiffness of the affected muscles brought on by reduced levels of dopamine (Cano-dela-Cuerda et al., 2011). An increase in passive muscle stiffness can cause two different types of rigidity,
lead-pipe rigidity and cogwheel rigidity (Endo et al., 2009). Lead-pipe rigidity is detected as a constant
force and defined as uniform resistance, while cog-wheel rigidity is detected as an intermittent force and
defined as on-and-off resistance shown in Figure 2 (Chunbao Wang et al., 2014). Rigidity, regardless of
the type, often begins in one arm and gradually spreads unilaterally to the leg, then through the trunk and
eventually to the other side of the body and is not always present during passive movement but can be
brought on by movement on the contralateral side of the patient such as opening and closing the patient’s
hand, known as Froment’s Maneuver (Association, E. P. D., 2016; Guttman & Furukawa, 2003).

Clinical Standard for Rigidity Assessment
The current standard for assessing rigidity in a clinical setting is a subjective test completed by
the clinician on the arm of the patient. This exam relies on the clinician to determine whether the level of
rigidity has increased based on the feel of the relaxed wrist and elbow joints as they perform passive
flexion and extension (Perera et al., 2019). Rating the perceived degree of rigidity during this exam and
comparing it to prior visits to determine if the perceived degree of rigidity has changed does not allow for
an accurate measure of rigidity, which can be made worse if the patient is experiencing tremors or cogwheel rigidity at the time of the exam, and lacks repeatability due to uncontrollable external factors. Due
to the varying rates at which rigidity develops from one patient to the next and the lack of reproducibility

3

of the diagnostic exam, the level of rigidity and progression of this critical PD symptom cannot be
quantitatively measured. The presence of quantitative data regarding progression of rigidity could lead to
more customized drug treatment options and an eventual increase in Health-Related Quality of Life
(HRQoL).

Diagnosing PD
Because of the variability and unpredictability of its symptoms and the overlap of symptoms with
other neurodegenerative disorders, a phenomenon described by the term Parkinsonism, PD can be
difficult to diagnose and treat effectively. In addition to the erratic nature of symptom presentation and
progression, the only definitive diagnostic test is one implemented post mortem and there are currently no
objective clinical measures of disease progression (Guttman & Furukawa, 2003; Merello & Antonini,
2019; Bhidayasiri, & Martinez-Martin, 2017). Because of this, much of the past PD research has been
dedicated to creating, testing, and improving subjective measures, while proposing and testing objective
measures for diagnosing and evaluating disease progression.

Clinical Standard for Diagnosis
The current clinical standard for diagnosing and determining approximate disease progression is a
combination of three parts, including: a complete neurological evaluation, in which the neurologist will
assess affected motor controls watching for any issues with gait, balance, and muscle tone; an in-depth
review of the patient’s medical history, including any prodromal symptoms; and subjective disease
surveys completed by the patient and clinician (Ford-Martin & Alic, 2005; Holden et al., 2018;
Downward, 2017). In an attempt to mimic the diagnostic process of expert clinicians and develop a
standard for those who have less experience, the Movement Disorder Society (MDS), created a diagnostic
tool aptly named the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson’s Disease
(MDS-PD Criteria). This guide was designed for use in research, but upon further testing, the MDS
observed high sensitivity and specificity of the criteria when compared with the current gold standard –
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diagnosis by an expert. This confirmed the diagnostic capability labeling the MDS-PD Criteria as a valid
clinical diagnostic tool (Postuma et al., 2018).

MDS-PD Diagnostic Criteria
The MDS-PD Criteria
explains that after motor Parkinsonism

Table 1: MDS Clinical Diagnostic Criteria for Parkinson’s Disease
MDS Clinical Diagnostic Criteria for PD
(Postuma et al., 2015)
(Postuma et al., 2015)

existence is determined, with help
from the MDS-UPDRS and defined by

Type of diagnosis
Clinically Established PD

the presence of bradykinesia (the core

1. Absence of absolute
exclusion criteria

feature of clinical PD) accompanied

2. At least two supportive
criteria

by either rigidity, resting tremor or

3. No red flags

both, a PD diagnosis can be

Clinically Probable PD
1. Absence of absolute exclusion
criteria
2. Presence of red flags
counterbalanced by supportive
criteria. If 1 red flag is present, there
must also be 1 supportive criterion.
No more than 2 red flags are allowed
in this category.

determined based on three categories of diagnostic features. Feature 1 – absolute exclusion criteria (a
negative feature that argues against PD diagnosis) is meant to rule out PD from other parkinsonisms;
feature 2 – red flags (another negative feature which must be offset by supportive criteria to allow
diagnosis), and feature 3 – supportive criteria (a positive feature that increase confidence of PD diagnosis)
(Tysnes & Storstein, 2017; Postuma & Berg, 2016). From these features there are two levels of diagnostic
certainty: clinically established PD and clinically probable PD. The requirements for the diagnosis of each
are shown in Table 1. Clinically established PD maximizes specificity, providing a reliable diagnosis
when the test is positive but not necessarily ruling out the disease when the test is negative. Whereas,
clinically probable PD balances specificity and sensitivity, considering more of the false negatives that
high levels of specificity neglect (Postuma et al., 2015).

Subjective Rating Scales
After a diagnosis is made, tests are conducted to determine approximate disease progression.
Rigidity along with other PD symptoms are evaluated subjectively in three prominent rating scales, the
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Movement Disorder Society’s – Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), the Hoehn
and Yahr Scale (H&Y), and the Parkinson’s Disease Questionnaire-39 (PDQ-39) (Ford-Martin & Alic,
2005; Holden et al., 2018; Downward, 2017; Bhidayasiri, & Martinez-Martin, 2017).

Movement Disorder Society’s – Unified Parkinson’s Disease Rating Scale
The MDS-UPDRS is a comprehensive ordinal rating scale created in the 1980s and revised by the
MDS in 2008 to reflect research and advances made since its creation (Goetz et al., 2008). The goal of
this rating scale was to provide an easy to use, comprehensive rating scale that would work for all PD
patients regardless of disease severity, current medications, or age. Proven through clinimetric testing to
be a reliable and valid tool for all stages of PD diagnosis and progression, the MDS-UPDRS has four
distinct parts, encompassing both motor and non-motor symptoms of PD. The four parts are Non-Motor
and Motor Experiences of Daily Living (NM-EDL, M-EDL), Motor Examination, and Motor
Complications. Each question has 5 possible answers relating to frequency or intensity, ranging from 0
(normal) to 4 (severe) (Goetz et al., 2008). The MDS-UPDRS is administered by a combination of a
clinician and the patient or caregiver, if necessary, depending on the section.

Hoehn and Yahr Scale
The H&Y scale is used to characterize progression of motor symptoms on a scale of 1 – 5 but
does not account for non-motor symptoms of PD (Barmore, n.d.). The H&Y scale, administered
completely by the rater, consists of five stages used to demonstrate the overall disease progression as
defined by the patient’s approximate level of disability (Goetz et al., 2008; Bhidayasiri, & MartinezMartin, 2017). Stage I of H&Y is considered early disease in which the patient experiences mild,
unilateral PD symptoms with minimal to no effect on function; Stage II is still considered early disease
like Stage I but includes bilateral symptoms and possibility of experiencing problems with speech,
rigidity, tremor, and bradykinesia; Stage III, considered mid-stage, is characterized by postural instability,
with falls becoming increasingly common, bradykinesia, and the ability of the patient to remain fully
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independent; Stage IV progression is severe and patients are noticeably incapacitated and unable to live
independently, needing some assistance in daily activities; Stage V describes a patient who is wheelchair
or bedridden, needing 24-hour assistance, and possibly experiencing hallucinations (Downward, 2017).
The ease of use and clear result of the H&Y have caused it to become a commonly adopted metric for
describing a patient’s PD stage throughout the progression of the disease (Bhidayasiri, & MartinezMartin, 2017); the patient’s H&Y rating is even included as a question in part three of the MDS-UPDRS
(Goetz et al., 2008).

Parksinson’s Disease Questionnaire - 39
The third and final subjective measure, the PDQ-39, evaluates the effects that PD has on the
patient’s Health-Related Quality of Life (HRQoL). This test is made up of 39 questions, completed by the
patient with multiple choice answers, regarding frequency of symptom manifestation, ranging from 0
(never) to 4 (always). As a measure of HRQoL and well-being, the PDQ-39 focuses on the impact that PD
has on the mental state, emotional state and the level of social functioning of the patient (Cano-de-laCuerda et al., 2011; Health Related Quality of Life and Well-Being, 2010).

These subjective measurements have been generally successful at diagnosing PD and determining
approximate disease severity because de novo diagnosis of PD and qualitative measurement of disease
progression are both based on symptoms that can be subjectively assessed by the patient and the clinician
(Guttman & Furukawa, 2003).

Objectives
While the subjective scaling systems currently in use have proved their efficacy in determining
overall disease progression of PD and will remain valuable assets in research and diagnostic efforts, it is
well known that quantification of disease state, including progression and severity of individual
symptoms like rigidity, is a necessity when it comes to PD monitoring and research. In these rating scales
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the information provided by the patient and the clinician is subjective and can change based on various
human and environmental factors present on the day the survey is administered (Guttman & Furukawa,
2003). However, studies show objective quantification of rigidity can be achieved by determining the
amount of torque needed to change passive joint position during externally imposed movement (Xia et al.,
2010). PD’s variability necessitates quantifiable objective measures in order to obtain unbiased results,
detect subtle changes in symptom progression, and simplify patient participation in future studies to better
understand the mechanisms of rigidity in parkinsonian disorders (Bhidayasiri & Martinez-Martin, 2017).
The goals of this study are to develop a torque-based device, using a servo motor, that will objectively
measure rigidity in the arm of patients suffering from PD and other movement disorders, to incorporate
necessary hardware-based safety features for safe operation and characterize the device to determine its
suitability for use in future research endeavors.

Previous Attempts
Motivation
Parkinson’s Disease progression, currently evaluated by subjective clinical scales, is monitored
and reported in terms of disease progression as a whole and not individual symptom progression. As a
result, inter-patient variability of symptom manifestation and progression is a known drawback of
diagnosing and tracking PD. As such, objectively quantifying rigidity, one of the cardinal features of PD,
would be useful for evaluating symptom progression, ultimately increasing treatment efficacy and
resulting in a better QoL. Rating scales, as the backbone of clinical standard for diagnosis, are limited by
their subjectivity. Since the mid-1900s there have been many attempts at objectively quantifying rigidity
but limitations, including lack of correlation with current rating scales and small sample sizes, have
prompted the absence of a clinically accepted standard (Prochazka et al., 1997). Recent research on the
quantification of rigidity has been focused on producing mechanical devices, equipped with sensors to
measure torque, angular velocity, and other variables during passive movement, for objective
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quantification. These mechanical devices can be delineated into two categories, rater-driven sensor
devices, and power-driven sensor devices which incorporate a drive such as a servo motor.

Rater-driven Sensor Devices
Before 1997, many methods were attempted using sensors to quantify rigidity however,
Prochazka et al. noticed that there were major differences between these methods and the standard clinical
exam. In their 1997 study, the clinical exam was completed on subjects while equipped with a force
sensing cuff and transducers to measure force and displacement gauge to measure changing position.
Torque (or limb impedance) was then calculated by multiplying the distance between the point of
application of the sensor and the elbow joint by the force. This study was completed on 14 patients with
mild to severe PD and the results were compared to the UPDRS at the time of the study. The subjective
rating of rigidity was determined for each patient by the clinician before the tests were performed a
second time with the cuff. The authors found that rigidity varied greatly during the clinical exams
monitored by the cuff but that during the standard clinical exam, a single number associated with rigidity
is given. As a result, this did not allow for accurate comparison between the clinical exam occurring with
and without the cuff. To avoid this limitation, during the exam with no cuff, the rater continually
verbalized their estimated rigidity rating. In this study there were observed differences in the speed and
range at which raters performed their tests but no statistical difference in the mean impedance between
raters was found, indicating that rater variability was not an issue. However, this study also examined
rigidity in the patient when on and off medications but found that while the calculated torque values were
different, the values perceived by the clinician were not, suggesting that the score of the rater was not
always a reliable assessment of rigidity. Because of the exclusion of the many influences of limb rigidity
in engineering tests, not only did this study conclude that “narrowing down” of test conditions using this
or other devices is contradictory to the clinical exam but also concluded that a simple device such as this
would allow for increased inter-rater reliability.
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In a similar study by Takayuki et al., in 2009, torque was calculated after measuring force with a
series of force sensors and a gyroscope, and distance from the elbow joint during passive flexion and
extension movements; however, EMG data was also collected, to analyze any myoelectric features during
passive movement of the limb. This study had a sample size of 51 patients, consisting of 24 healthy older
adults and 27 PD patients with rigidity ranging from mild to moderate and rated each patient using the
MDS-UPDRS before any testing was completed. A hold-ramp-hold-ramp-hold movement was
implemented starting at maximum flexion to determine muscle tone during flexion and extension. The
authors found that rigidity values based on the calculations of torque did not correlate well to the UPDRS
because the muscular dynamics of rigidity differ between flexion and extension, further demonstrating the
limitations of the current clinical procedure. As a result, the authors defined rigidity as a sum of an
“elastic” component and average force which they termed “difference of bias” and noted that the most
studies do not differentiate between flexion and extension scores during testing.
Ultimately the authors in both studies noted that further study was needed to determine how to
mimic current clinical standard exams in a controlled environment while monitoring all test parameters
including muscle tone during passive flexion and passive extension.

Power-driven Sensor Devices
Each of these studies considered subjective testing an insufficient tool to monitor changes in
rigidity and considered the quantification of rigidity important for determining and increasing efficacy of
drug treatment methods. The basis of the device used to measure rigidity by Relja, Petravic, and Kolaj
(1996) is an electromotor that drives an “arm board” equipped with a torque transducer and a
potentiometer used to simultaneously measuring torque and position, with a constant velocity, through
phases of passive flexion and extension. “Net work” was calculated as a measurement of rigidity and
represented by the area of a hysteresis diagram. Each of 127 subjects, made up of 24 PD patients and 103
controls, was evaluated using the UPDRS before the trial. The authors also measured rigidity with respect
to activation of the contralateral limb known as activated rigidity when patients were on and off
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medications to determine differences before and after treatment. The study was deemed repeatable, and
clinically reliable when compared to subjective ratings of rigidity. In spite of this, the small sample size of
PD patients and comparatively limited disease knowledge were the main limitations of the study.
In a 2002 study by Powell et al., the authors sought to determine the effects of velocity and
amplitude on rigidity during passive movement and to determine the effects of dopaminergic medications
on rigidity. The device used in this study consisted of a servo motor and shaft attached to the end of a
manipulandum. Torque and position were measured about the wrist during ramp and hold trajectory for
four different combinations of velocity and angle of displacement. Surface EMG was also measured on
the wrist and finger flexor muscles for each patient. The initial measurement occurred when patients were
off medication for at least 12 hours and then tests were completed again after their normal dose was
administered. Hysteresis curves of torque with respect to joint position were analyzed along with EMG
data. The authors found that the greater the angle of displacement, the greater the value of rigidity,
determining that rigidity is dependent on amplitude though the this contradicts the clinical description of
rigidity as constant passive stiffness. These authors also found that rigidity did not significantly decrease
due to dopaminergic medication however a major limitation is the single orientation in which this study
measured rigidity compared to the three-dimensional movements assessed in clinical exams.
Together, these studies explore only a few of the causes associated with and tests quantifying and
treating parkinsonian rigidity. Small sample sizes, a lack of correlation with clinical standards and clinical
testing procedures, and lack of complete joint modeling are just a few of the hurdles necessary to
overcome to objectively quantify joint rigidity.
A third study (Sin et al., 2019), used a robotic device to improve repeatability, and inter-rater
reliability while measuring spasticity in stroke patients during stretch reflex measurements. While
spasticity is not the same as rigidity, the device design is relevant and is composed of a torque sensor, a
processor, an encoder, a motor, a controller and a forearm manipulandum style arm sling. The arm sling
uses linear sliders to perfectly adjust the length from the axis of rotation to the manipulandum handle and
position of restraints to fit each individual patient and to ensure that the elbow is aligned about the axis of
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rotation. In this study, the adjustable arm sling allows for repeatability in testing and the controller allows
for inter-rater reliability. Adopting the concept of creating an adjustable arm sling would allow for
increased inter-rater reliability and thus repeatability while measuring torque.

Methods
Device Setup
To quantify rigidity, a torque-based device was designed to be used on a patient’s arm. The
device consists of three key inter-connected components (Figure 3). The first, called the motor assembly,
utilizes a 20KΩ, heavy-duty, multi-turn, precision potentiometer (Bourns, 3540S-1-203L) to measure
shaft position of the servo motor (Kollmorgen, JR16M4CH/ENC), a transmission-shaft assembly,
equipped with a torque transducer (Sensotec, QSFK-9/J301-01) to measure torque, two photologic slotted
optical switches (TT Electronics, OPB991) to limit the angle of rotation, and a rigid forearm sling. The
connections of this assembly run through an emergency power shut-off junction box for organization of
electrical connections and added safety. The second component, called the controller/power assembly
contains data processing components and the power supply components of the device including a
transducer power supply (Transducer Techniques, Model PSM-R), a 12000 µF electrolytic capacitor

Figure 3: Device Setup (not pictured: computer, D/A, and A/D converters)
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(Vishay Sprague Powerlytic™, 36DY), Variac transformer (Staco, 1010B), servo amplifier/controller
(Advanced Motion Controls, 25A20), 12V DC power supply, and safety circuit board. The two
compartments are connected via a DB-15 connecter cable in order to provide the device’s input and
output signals, and a locking power cable to power the motor. The third assembly consists of the external
data processing equipment including an analog-to-digital (A/D) and a digital-to-analog (D/A) converter, a
computer, and an oscilloscope (Agilent Technologies, DSO-X 2024A) used for viewing real-time data.
An isolation transformer (Toroid, ISB-060A) is used to avoid ground loops and isolate the common
ground for the device and power ground from the outlet. A full list of parts can be found in Appendix 1.
The connections between and within these components can be seen in Figure 4 and Figure 5. Using an
MS DOS computer platform, stimulus signals are sent through the controller/power assembly to the motor
while position and torque data are sent through the controller/power assembly to the computer

Figure 4: Isolation Transformer
Block Diagram

Figure 5: Device Block Diagram

13

simultaneously. Working together, these three components flex and extend the elbow joint to mimic the
movements during rigidity testing in the current standard clinical setting and the combination of position
and torque data are used as a measurement of rigidity with respect to time.

Features of the Motor Assembly
The motor assembly, shown in Figure 6, consists of several
components that drive the motor and track torque and position during
each experiment. The servo motor is the basis of the assembly and
allows for precise control of rotation. Attached to one end of the motor is
the multi-turn potentiometer, which monitors lateral position of the
patient’s arm. The output of the potentiometer is an analog signal
directly correlated to position with respect to time. Attached to the
opposite end of the motor is the transmission-shaft assembly, which can
rotate 90° to allow for measurement of torque about the horizontal or

Figure 6: Motor Assembly (not
pictured: mounted optical switches,
DB-15 inter-assembly connector)

vertical axis. Two optical switches are affixed at the base of the shaft on the
transmission to a 3D printed mount that allows for different heights of the
two sensors. These sensors work in conjunction with two 3D printed shaft

Figure 7: 3D model of the
photologic optical switch mount

collars with attached brass vanes. The printed shaft collars contain small set
screws that allow for positional adjustments of the collars and vanes. The
maneuverability of the shaft collars allows for restriction of the angle of rotation of the
rigid arm sling as a safety precaution (more information is included in Hardware Safety

Figure 8: 3D
model of a shaft
collar

Features). The torque transducer is located towards the top of the shaft to measure torque as the shaft
rotates and the rigid forearm sling is affixed at the top of the shaft, with its axis of rotation about the shaft.
The output voltages of the potentiometer, torque transducer, and two optical switches and power inputs
for the torque transducer, optical switches, potentiometer and servo motor are all fed through a plastic
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junction box equipped with a red emergency power shut-off button which when pressed disconnects
power to the motor and must be twisted in order to be released.

Controller/Power Assembly
The controller/power assembly contains data processing
components and the power supply components of the device
including a transducer power supply, 12000µF electrolytic capacitor,
Variac transformer, servo amplifier/controller, 12VDC power supply,
and safety circuit board. The transducer power supply is a bipolar
supply that powers only the torque transducer. There is also an

Figure 9: Controller/Power Assembly
front view

isolated 12VDC power supply that is used to power the TTL safety
circuit board. Separate power supplies are needed because the safety
circuit and torque transducer together exceed the current limits of the
transducer power supply. However, it is important to note that all
ground signals within this device are common, including the chassis,

Figure 10: Controller/Power Assembly
top view

to avoid ground loops. The Variac transformer, motor supply circuit,
and transducer power supply provide power to the servo motor and
torque transducer. The servo amplifier/controller is designed to drive
DC motor with precision and is one of the most important components
because it controls the motor. Using a negative feedback loop the
controller analyzes the position of the motor with respect to the

Figure 11: Controller/Power Assembly
rear view

position of the input stimulus. If there is any difference between the two signals >~100mV, the servo
motor, driven by the shaft position difference with the motor, produces a step change in position to
minimize the error. These movements are intense, jolting movements and while not unsafe, they can be
uncomfortable. For this reason, the position of the sling should be adjusted so that the potentiometer
signal and stimulus signal are equal before the inhibit is reset. The output of the safety circuit is also
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monitored by the controller using the inhibit feature. This feature is used to implement limits that when
triggered will shut down the motor by pulling the inhibit signal to ground. Under normal and safe
conditions, the output of the safety circuit to the inhibit pin is 5V. In accordance with the safety circuit,
when unsafe conditions are met, the output of the circuit drops to 0V and stays there until the device is the
device is reset, causing the controllers inhibit to trigger.

Hardware Safety Features
To ensure the safety of any participant, a transistor-transistor logic (TTL) based digital safety
circuit was designed using integrated circuits to interact with the inhibit feature on the controller. All
connections were installed onto a circuit board using a combination of solder and wire wrapping, a
technique that produces connections more durable than those made strictly with solder and allows for
more simple modifications. When the inhibit signal on the controller is pulled to ground (0 volts), the
controller cuts power to the motor. To make this device safe, we incorporated three limits into the circuit
design, position, velocity and torque.

Figure 13: Safety circuit board (back view and
wire wrap connections)

Figure 12: Safety circuit board (front view)
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Figure 14: Logic Circuit Schematic

Position Limit
The position limit (Figure 15)
restricts shaft angle of rotation and includes
two photologic slotted optical switches
mounted at the base of the shaft and two
shaft collars, with brass vanes attached,
tightened onto the shaft using set screws.
During testing, the shaft collars were set to

Figure 15: Visual representation of the position limit
viewed from above transected shaft.

ensure that the rigid arm sling would not
rotate more than 90° but can be adjusted to desired angle. As the shaft rotates, the vanes of brass rotate
with the shaft. When either vane passes through the slot of an optical switch, interrupting the signal, the
output of that optical switch drops to 0 volts(V), known as logical LOW. A hex inverter (Texas
Instruments, SN74LS04N) was used to invert the logic signal of the optical switches so they would match
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the logic of the quad differential comparator (Texas Instruments, LM339) which goes to 5V, or logical
HIGH, upon exceeding its limit.

Torque and Velocity Limits
Three comparators on a quad comparator chip were used to evaluate limits set for velocity and
torque. Position data from the potentiometer was differentiated using a High Pass Filter (HPF) (Figure 16)
to attain velocity and amplified to counteract the effects of the HPF on the signal. These values of
velocity were compared to reference values using the comparator. The torque values from the torque
transducer were also passed through the comparator. Because the potentiometer is bi-directional, the
values received from the potentiometer are both positive and negative and must be analyzed as such. The
TTL logic of the comparator states that if input voltage (Vin)>reference voltage (Vref) the output is a
logical 1 or 5V (HIGH), whereas if Vin<Vref the comparator output is LOW. Standard comparator logic
does not work for negative values, so we created a window comparator that allows for the comparator to

Figure 16: High Pass Filter Schematic

judge based on a reference window instead of a single reference value. If the source signal is between the
two reference values (within the window) the output is LOW, but if the source signal falls outside of the
reference signal the comparator output goes HIGH.
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Position, Torque, and Velocity Create the Inhibit Signal
Next, all three outputs of the comparator are sent to a dual 5-input positive-NOR gate (Texas
Instruments, SN74F260) which evaluates inputs based on the NOR logic (Figure 17) and combines them
into one output; if any input is high the output of the NOR is LOW. The inverted signal from the optical
switches is also sent to the NOR gate so that if any one of these devices is tripped (HIGH), the output of
the NOR is LOW. The signal output of the NOR matches with the logic of the inhibit pin but a latching
mechanism was needed in order to make sure the device
turned off and stays off instead of turning back on as soon
as the error is resolved. To achieve this, a quadruple setreset (S-R) latch (Texas Instruments, SN74LS279A) was

Figure 17: NOR Logic
(http://www.eeherald.com/section/design-guide/logic-design.html)

used along with a single pull, single throw (SPST) always
off-momentarily on (OFF-MOM) push button switch
(Grayhill) and a 3-lead bi-color LED (Bivar, PM53KNBCW12.0) indicator light which turns red if the inhibit
signal has been tripped and stays green at all other times.
The output of the S-R latch (which stays latched until

Figure 18: Set-Reset Latch Logic. Output = Q
(https://www.allaboutcircuits.com/textbook/digital/chpt-10/s-rlatch/)

manual reset, Figure 18) is sent to the controller as the input for inhibit. When the inhibit feature is active
(meaning there is an issue), the indicator light will be red, the motor will be off, and the push-button
switch will have to be pushed just once in order to reset.
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Additional Components of the Safety Circuit
In addition to the logic components of
this circuit, there are several others necessary
for the safety circuit to work. These include the
negative voltage converter (Figure 19), which
converts a +12V into -10V to be used as Vin for
several of the devices using a switchedcapacitor voltage converters with regulators

Figure 19: Negative Voltage Converter Schematic

(Texas Instruments, LT1054), the adjustable
linear voltage regulator (STMicroelectronics, LM317T) (Figure 20), which regulates 12V down to 10V,
the five volt fixed voltage regulator (Texas Instruments, LM340T) (Figure 21), and the high pass filter
(Figure 16), needed to differentiate and analyze the position data. Together these TTL devices form the
hardware-based safety features for this device.

Figure 20: Adjustable Regulator Schematic
Figure 21: 5V regulator Schematic

Data Processing Assembly
The software used for processing the data was software created and modified by Dr. Paul Wetzel
using a MS DOS platform in line with an external A/D and D/A converter. The program provided
stimulus files to the controller and the A/D sampled the potentiometer and torque data each at a sampling
rate of 500Hz. Because these stimulus files were created for a different use, we attenuated the ramp and
sine files using an external potentiometer.
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Connections Between Assemblies
A DB-15 cable was used to make each connection from the motor assembly to the
controller/power assembly aside from the power cable for the motor which was connected with an
industrial grade non-shrouded locking plug to ensure that the motor would not become disconnected from
power by mistake. Device signals were sent to and from the controller/power assembly and the data
processing equipment with BNC cables.

Figure 22: Potentiometer Offset-Summing Amplifier Schematic

Participants
In lieu of the restrictions due to the COVID-19 pandemic, no PD patients were available, and no
study was able to take place. Instead, evaluation was completed on two healthy individuals, person 1 and
person 2, identified by GM and PW, respectively. To simulate a scenario with increased torque, as is the
case with Parkinsonian rigidity, individuals were instructed to co-contract the muscles surrounding their
elbow joint by clenching the fist of the tested arm. Tests were run on the right arm of each participant.
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Evaluative Protocol
Person 1 and person 2 were instructed to stand perpendicular to the table next to the device, with
their right hip touching the side of table. The individual’s right arm was then placed in the sling with their
elbow sitting directly over top of the shaft and their palm positioned outward with their thumb toward the
ceiling. The arm was secured with two Velcro straps, one at the wrist and one just below the elbow, to
restrict movement of the arm within the sling. The position of the rigid arm sling was then moved to the
zero position, as seen on the oscilloscope, by rotating the shaft until the position signal on the scope
matched that of the stimulus signal; in this case the stimulus file was programmed so that it started and
ended the signal at zero volts. The zero position of the potentiometer correlated to a flexion angle of
approximately 45° about the elbow. This setting can be altered by turning the potentiometer by hand and
should be decided upon based on the content of the stimulus file, for example, when using a sine wave,
which oscillates above and below zero periodically, you must start the device in the center of the range of
motion.
Directions were given to the
individual to relax their limb as much
as possible during relaxed tests and
make a tight fist during the entirety of
the co-contraction tests. Three stimuli
were applied including, sinusoidal
stimulus (sine3.dat), a ramp stimulus

Figure 23: Arm shown during
relaxation

Figure 24: Arm shown during cocontraction or clenched-fist phase

(ramp3.dat), and a random stimulus (rnd-100f.dat) made up of sinusoidal
content of varying amplitude and frequency. The forearm was displaced through a maximum total range
of 90° (+/- 45° from the zero position). Each person underwent two trials of each stimulus type, one with
a relaxed joint and one under co-contraction. Each stimulus file was also run with no load to determine
the level of device noise for each test. Data from the torque transducer and potentiometer were sampled at
a rate of 500 Hz. Using a stand-alone six degree of freedom magnetic tracking system called, A Flock of
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Birds (Ascension Technologies, Colchester, VT), angle (yaw, pitch, and roll) and position (x, y, z) data
was also collected at a rate of 125 Hz and expanded to 500 Hz, by repeating each value four times, to
allow for comparison between the files and to determine the degree of yaw, pitch and roll of the device
arm.

Data Analyses
Torque and position output voltages for relaxation and co-contraction evaluations were
graphically compared with respect to time for each different stimulus. Mean and variance were also
calculated for torque in each trial and compared to one another within their stimulus category. Using a
custom code written by Dr. Paul Wetzel, Discrete Fourier Transforms were performed on the torque data
to determine the frequency content of the random and sine stimuli.

Results
Comparison of Velocity to Stimulus Position
To determine efficacy of the HPF, the velocity was sampled instead of torque during a test run of
the random stimulus with no load. In the graph of velocity and position with respect to time, shown in
Figure 25, we expected to see the velocity curve, shown in red, phase shifted to the right of the stimulus
file. This graphical representation proves that the HPF is differentiating position into velocity.
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Figure 25: Values for position and velocity with device under the “no-load” condition.

Quantification of Perceived Rigidity in Co-contracted Versus Relaxed Trials
Perceived rigidity during co-contraction and during relaxation was compared for each person and
for each stimulus signal. During the relaxed tests for sine (Figure 32 and Figure 34) and random stimuli
(Figure 27 and Figure 29), the torque values are relatively low with a couple of peaks following
significant changes in the stimulus. During the co-contraction tests for sine (Figure 33 and Figure 30) and
random stimuli (Figure 28 and Figure 30), the peaks are larger meaning that perceived torque is greater
during the clenched-fist phase than during the relaxed phase. This makes sense based on prior research.
During the ramp stimulus, there is not a significant difference between torque during co-contraction
(Figure 38 and Figure 40) and during relaxation (Figure 37 and Figure 39). Median torque and variance
were also calculated for each test resulting in exceptionally low variances (Table 2, Table 3, and Table 4).

Figure 26: Torque values for the Random stimulus with no load.
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Figure 27: Torque values for the Random stimulus during relaxation for GM.

Figure 28: Torque values for the Random stimulus during co-contraction for GM.
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Figure 29: Torque values for the Random stimulus during relaxation for PW.

Figure 30: Torque values for the Random stimulus during co-contraction for PW.
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Figure 31: Torque values for the Sine stimulus with no load.

Figure 32: Torque values for the Sine stimulus during relaxation for GM.

Figure 33: Torque values for the Sine stimulus during co-contraction for GM.
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Figure 34: Torque values for the Sine stimulus during relaxation for PW.

Figure 35: Torque values for the Sine stimulus during co-contraction for PW.
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Figure 36: Torque values for the Ramp stimulus with no load.

Figure 37: Torque values for the Ramp stimulus during relaxation for GM.

Figure 38: Torque values for the Ramp stimulus during co-contraction for GM.
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Figure 39: Torque values for the Ramp stimulus during relaxation for PW.

Figure 40: Torque values for the Ramp stimulus during co-contraction for PW.
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Table 1
Mean and Variance Values for Torque from a Random
Table 2: Mean and variance values for torque from the random stimulus
Stimulus

No-load

Random Stimulus
GM (R)
GM (C)

PW (R)

PW (C)

Mean

0.01250

0.04254

-0.04380

0.04271

0.07009

Variance

0.00017

0.00277

0.01031

0.00337

0.00891

Note: (R) stands for relaxed arm, (C) stands for co-contracted arm.
Mean and variance calculated for torque values which are measured
in volts (V).

Table 3
Mean and Variance Values for Torque from a Ramp
Table 3: Mean and variance values for torque from the ramp stimulus
Stimulus

No-load

Ramp Stimulus
GM (R)
GM (C)

PW (R)

PW (C)

Mean

0.01205

0.03047

-0.04883

0.03382

0.01974

Variance

0.00209

0.00411

0.00920

0.00628

0.01189

Note: (R) stands for relaxed arm, (C) stands for co-contracted arm.
Mean and variance calculated for torque values which are measured in
volts (V).

Table 2
Table 4: Mean and variance values for torque from the sine stimulus
Mean and Variance Values for Torque from a Sine Stimulus

No-load

Sine Stimulus
GM (R)
GM (C)

Mean

0.01206

0.03145

-0.04351

0.04300

0.04835

Variance

0.00021

0.00038

0.00227

0.00037

0.00098

PW (R)

PW (C)

Note: (R) stands for relaxed arm, (C) stands for co-contracted arm. Mean
and variance calculated for torque values which are measured in volts
(V).
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Stimulus Frequency Content
A Discrete Fourier Transform (DFT) was conducted, based on the chirp-z algorithm, on the sine
and random position data to determine the frequency content of each waveform. The sine data had a peak
magnitude at 0.35 Hz which is the known frequency content of the sine wave. The random signal had
many peak magnitudes because it consisted of varying different sinusoidal signals. The frequency content
of the waveform will never change with this setup because the motor controls the sling and does not allow
for any position differences because of the negative feedback loop with the controller. This is shown in
the graph below where the peak magnitudes for relaxed and co-contracted trials are the same.

RND DFT - GM

0.35

RND-GM20 (Cocontracted)
RND-GM10
(Relaxed)

Frequency [Hz]

0.3
0.25
0.2
0.15
0.1
0.05

0
-0.05 0

0.25

0.5

0.75

1

1.25

1.5

1.75

2

Time
Figure 41: Frequency content of position in the random stimulus

Device Rumble
Roll, pitch and yaw were measured using a magnetic tracker and tracking device, which was
attached directly behind the elbow on the rigid arm sling at the point of rotation. The roll and the pitch are
of interest because there is a slight amount of play in the device due to space between the gear teeth in the
transmission. The values of roll, seen in (Figure 46 and Figure 47), were less when there was no load in
the device but there was no significant difference between the relaxed and co-contracted phases. The
reverse was the case for pitch (Figure 44 and Figure 45), which was higher when there was no load than
while tests were run. Like the roll values, the measured pitches during co-contraction and during

32

relaxation were remarkably similar. The measured yaw (Figure 42 and Figure 43) should have changed a
lot because that was the orientation of movement but it seemed to change the least.

Figure 42: Yaw of the device during relaxation for GM and PW vs. during no-load condition.

Figure 43: Yaw of the device during co-contraction for GM and PW vs. during no-load condition.
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Figure 44: Pitch of the device during relaxation for GM and PW vs. during no-load condition.

Figure 45: Pitch of the device during co-contraction for GM and PW vs. during no-load condition.
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Roll During Relaxation vs. No-Load
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Figure 46: Roll of the device during relaxation for GM and PW vs. during no-load condition.

Figure 47: Roll of the device during co-contraction for GM and PW vs. during no-load condition.
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Discussion
Sine, Discussion Ramp and Random Waveform Characterization
The main finding of the current study was the ability to objectively determine torque needed to
flex and extend the elbow joint with respect to a specific stimulus signal. The random and sine signals
show promise but there was too much force behind the abrupt changes of direction during the ramp
stimulus and it does not mimic natural movement, nor does it mimic the clinical exam used to determine
rigidity. These abrupt, sudden changes in direction, accentuated due to the negative feedback loop, led to
similar torque values during relaxation and co-contraction and seemed to lightly shake the table while
tests were being run. As such the ramp3.dat stimulus used in present form is not recommended, however a
ramp and hold stimulus, which allows for softening of the abrupt changes, remains a possible solution.
During the relaxation tests of the random stimulus, most of the peaks in torque were accompanied
by larger amplitude peaks during co-contraction. Although in (Figure 28), the torque signal during cocontraction appears to have an offset and two of the peak torque values during relaxation are larger than
their co-contraction counterparts. The torque transducer, is directional, meaning that a value below zero
indicates torque in the opposite direction, not a lack of torque. However, human error is likely as this
offset was repeated by person 1 in the sine tests (Figure 33) but did not occur for person 2 in either test.
Another possible reason could be attempted resistance to the movement by doing more than just cocontracting the muscles surrounding the elbow. In this case though the two peaks shown during the
relaxation phase look larger than the co-contraction peaks prompting further explanation. Without
measuring muscle activity during co-contraction and relaxation we cannot determine the exact reason for
these peak magnitudes. However, they occur at the highest velocities of the stimulus and seem to be
prompted by a change in direction. These larger magnitude peaks during relaxation could also be showing
a natural reaction of the body to co-contract due to sudden change in direction and high speeds, like those
in the ramp stimulus.
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For the sine waves, the torque values appear to be larger during co-contraction than they are
during relaxation although the offset was still present for person 1. Because we were unable to measure
co-contraction in the surrounding muscles, we cannot definitively determine a cause for the offset or the
torque peaks during the relaxation phase.

Calculated Variance
Mean and variance were both calculated for torque in each trial and for each person. The
variances are all extremely small and instead of looking at the variance itself, the proportion of relaxed
phase variance to co-contracted phase variance was calculated. Even though the variances overall are
low, meaning the spread beyond the median is small, the variance for the co-contracted phase shows a
value at least 25% higher than that of the relaxed phase in the sine and random stimuli. This would mean
that average torque values are higher in the co-contraction phase than during the relaxed phase. During all
three stimuli, and with each of the subjects the calculated variances were higher in the co-contracted data
than in the relaxed data although the variances from the ramp data had the lowest increases.

Frequency Response (DFT)
The DFT of a stimulus during relaxation and co-contraction will look the same regardless of
torque because the position of the signal is the same for each change. DFT measures frequency content of
a waveform and because of the presence of the negative feedback loop in the controller, the position data
is the same during relaxation and co-contraction. The DFT of the random file has many different
magnitude peaks relating to the changing frequency of the random stimulus. The sine stimulus used has
only one peak at 0.35 Hz which is to be expected due to the known frequency content of the sine wave.

Limitations and Suggested Improvements
There were many limitations in this preliminary study, including the small sample size and the
absence of PD patients. The device was also not evaluated for use in the vertical plane. Although the
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results are repeatable, co-contraction was not constant throughout each test run or between stimuli and
without further evaluation we would not be able to determine the varying degrees of co-contraction
throughout the test. Each stimulus file was run multiple times before recorded tests were run and greater
torque during co-contraction was a result in those as well. Though co-contraction is a good alternative in
this situation, a preliminary study consisting of PD patients to see a comparison of torque in a PD patient
population versus a control group should be completed.
In addition to the limitations of the study itself, there are a few serious factors with respect to
clinical use that must be considered, including the backlash in the transmission which could be
remediated by removing the transmission altogether as the servo motor was made for precise movement.
Unfortunately, the transmission is what allows the shaft-sling assembly to rotate into the lower position
and the device would no longer have the capability of measuring in two different planes. In order to retain
this ability, transmission updates to decrease the clearance between the gear teeth if possible or obtaining
a higher precision transmission would decrease backlash.
The feedback mechanism also must be considered when selecting patients for a future study.
Because the motor will force the patients arm to move regardless of ability, a patient’s range must be
examined before determining candidacy. While limits may be set to ensure the device does not exceed a
certain angle of rotation, each participant should be evaluated for range of motion in their elbow joint
prior to involvement to ensure safety.
The device is also not easily portable. It can be carried by a single person, one assembly at a time
but it is bulky and unfortunately many of the components are heavy. There is also currently no height
adjustment and so the device itself is not customizable to people of varying heights, or for those who
cannot stand. The device is tall and therefore would need to be placed on a shorter table or an adjustable
height stand so that it could easily be moved higher or lower to allow for height adjustments. On a
standard height table, the device must be used while standing. Furthermore, there is no way to immobilize
the rest of the patient’s body during testing. A seated approach would allow for a smaller overall height
range and test subjects could be restrained more easily.
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While this is not a necessary upgrade, a modified arm sling would provide patients with more
comfort, better restraint of the limb, and it would ensure that each patient’s arm is tested about the same
point. The current sling is made to be one size fits all with Velcro straps used to position the forearm and
hold it in place, but it is not very comfortable. I suggest a modified partially 3D printed arm sling with the
ability to increase length of the sling, and a manipulandum to ensure proper rotation of the wrist, similar
to the example from Sin et al. (2019) These modifications would increase repeatability and provide
comfort for the patient

Future Directions and Conclusions
Although this device has not yet been tested on PD patients, the preliminary results of torque
measured in phases of co-contraction and relaxation during passive flexion and extension of the forearm
of two healthy individuals proves that this device does effectively measure torque. In addition, the safety
features included in the TTL safety circuit will allow for reliable operation of the device in a research
setting. In correlation with the clinical standard subjective rating scales, this device could be used to
objectively quantify torque, and therefore rigidity, in the elbow joint of patients to better understand the
mechanisms of rigidity in those suffering from Parkinson’s and other movement disorders.
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Appendix 1: Parts List
Part Name
12 VDC Power Supply
20 KΩ Multi-turn Precision
Potentiometer
12000µF Powerlytic™ Capacitor
Medical Grade Isolation Transformer
Photologic Slotted Optical Switch
Servo Amplifier/Controller
Servo Motor
Torque Transducer
Transducer Power Supply
Transmission
Variac Transformer
100K Ω Trimpot®
10K Ω Trimpot®
1K Ω Trimpot®
20K Ω Trimpot®
3-Lead Bi-Color LED
500 Ω Trimpot®
5K Ω Trimpot®
5V Fixed Voltage Regulator
Adjustable Linear Voltage Regulator
Capacitors
Diodes
Dual 5-Input Positive-NOR Gate
Heat Sink
Hex Inverter
Monolithic Sample-and-Hold Circuit
Push-Button Switch
Quad Differential Comparator
Quadruple S-R Latch
Resistors
Re-triggerable Monostable Multivibrator
"One-shot"
Silicon NPN Transistor
Switched-Capacitor Voltage Converters
with Regulators
Ultraprecision Operational Amplifier

Part Number
SDI18-12-UC-P5

Qty.
1

Manufacturer
CUI Inc.

3540S-1-203L

1

Bourns

36DY
ISB-060A
OPB991
25A20
JR16M4CH/ENC
QSFK-9/J301-01
Model PSM-R
Unknown
1010B
W104
W103
W102
W203
PM53-KNBCW12.0
W501
W502
LM340T
LM317T
----1N914
SN74F260
----SN74LS04N
LF398N
30-6
LM339
SN74LS279A
-----

1
1
2
1
1
1
1
1
1
1
1
2
1
1
1
1
1
1
12
3
1
2
1
1
2
1
1
30

Vishay Sprague Powerlytic™
Toroid
TT Electronics
Advanced Motion Controls
Kollmorgen
Sensotec
Transducer Techniques
Motovario
Staco
Bourns
Bourns
Bourns
Bourns
Bivar
Bourns
Bourns
Texas Instruments
STMicroelectronics
See Appendix 2
Vishay
Texas Instruments
N/A
Texas Instruments
Texas Instruments
Grayhill
Texas Instruments
Texas Instruments
See Appendix 2

SN74LS123N

1

Texas Instruments

2N2222

1

Central Semiconductor Corp.

LT1054

1

Texas Instruments

OP177

3

Analog Devices, Inc.
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Appendix 2: Resistor and Capacitor List

Resistors
Number:
Value:
R1
4.02K Ω
R2
5.11K Ω
R3
5.11K Ω
R4
301 Ω
R5
126 Ω
R6
309 Ω
R7
105 Ω
R8
126 Ω
R9
309 Ω
R10
105 Ω
R11
301 Ω
R12
301 Ω
R13
30.1 Ω
R14
20K Ω
R15
180K Ω
R16
5.11K Ω
R17
10K Ω
R18
475 Ω
R19
5.49K Ω
R20
174 Ω
R21
15K Ω
R22
15K Ω
R23
15K Ω
R24
13.7K Ω
R25
13.3K Ω
R26
1K Ω
R27
4.99K Ω
R28
5.23K Ω
R29
5.23K Ω
R30
5.23K Ω

Number:
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
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Capacitors
Value:
Type:
10 µF
tantalum
22 µF
tantalum
0.0022 µF
mylar
100 µF
electrolytic
0.1 µF
mylar
2.2 µF
mylar
2.2 µF
mylar
100 µF
electrolytic
0.1 µF
mylar
1 µF
tantalum
10 µF
electrolytic
0.1 µF
mylar

